or Try an Advanced Search...

    Technical Analysis for XAIR - Beyond Air, Inc.

    Grade Last Price % Change Price Change
    D 0.49 -6.29% -0.03
    XAIR closed down 6.29 percent on Wednesday, November 20, 2024, on 61 percent of normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Down
    Historical XAIR trend table...
    Date Alert Name Type % Chg
    MACD Bearish Signal Line Cross Bearish 0.00%
    20 DMA Support Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    Wide Bands Range Expansion -6.29%
    Outside Day Range Expansion -3.38%
    Wide Bands Range Expansion -3.38%
    NR7 Range Contraction -1.97%
    Inside Day Range Contraction -1.97%
    Wide Bands Range Expansion -1.97%
    Wide Bands Range Expansion -7.25%
    Older End-of-Day Signals for XAIR ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 18 hours ago
    Down 5% about 18 hours ago
    Down 3% about 18 hours ago
    Fell Below Previous Day's Low about 18 hours ago
    Fell Below 10 DMA about 18 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    XAIR Chart by TradingView
    Basic chart:

    Profile

    Beyond Air, Inc. Description

    Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The Beyond Air NO Delivery System can generate up to 400 ppm of NO for delivery either continuously or for a fixed amount of time and has the ability to either titrate dose on demand or maintain a constant dose. The Company is currently applying its therapeutic expertise to develop treatments for pulmonary hypertension in various settings, in addition to treatments for lower respiratory tract infections that are not effectively addressed with current standards of care. Beyond Air is currently advancing its revolutionary NO Generator and Delivery System in clinical trials for the treatment of bronchiolitis and severe lung infections such as nontuberculous mycobacteria (NTM).

    Classification
    Sector: Industrials
    Industry: Conglomerates
    Keywords: Medicine Biopharmaceutical Hypertension Coronavirus Pulmonary Hypertension Tuberculosis Bacterial Disease Bacteriology Lung Infection Nontuberculous Mycobacteria Lower Respiratory Tract Infection Lung Infections Mycobacterium Respiratory And Other Diseases Respiratory Tract Respiratory Tract Infection

    Is XAIR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference
    Nov 12 Beyond Air, Inc. (XAIR) Q2 2025 Earnings Call Transcript
    Nov 11 Beyond Air GAAP EPS of -$0.28 in-line, revenue of $0.79M misses by $0.24M
    Nov 11 Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update
    Nov 11 Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
    Nov 11 Earnings Scheduled For November 11, 2024
    Nov 8 A Peek at Beyond Air's Future Earnings
    Oct 29 Beyond Air® Schedules Second Fiscal Quarter 2025 Financial Results Conference Call and Webcast
    Oct 25 Beyond Air files to sell 81.7M shares of common stock for holders
    Oct 7 Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
    See more XAIR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.3599
    52 Week Low 0.296
    Average Volume 666,299
    200-Day Moving Average 0.95
    50-Day Moving Average 0.42
    20-Day Moving Average 0.49
    10-Day Moving Average 0.50
    Average True Range 0.05
    RSI (14) 53.70
    ADX 20.89
    +DI 19.65
    -DI 15.80
    Chandelier Exit (Long, 3 ATRs) 0.43
    Chandelier Exit (Short, 3 ATRs) 0.51
    Upper Bollinger Bands 0.57
    Lower Bollinger Band 0.40
    Percent B (%b) 0.54
    BandWidth 34.10
    MACD Line 0.03
    MACD Signal Line 0.03
    MACD Histogram -0.0008
    Fundamentals Value
    Market Cap 17.51 Million
    Num Shares 35.6 Million
    EPS -2.05
    Price-to-Earnings (P/E) Ratio -0.24
    Price-to-Sales 223.45
    Price-to-Book 2.60
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.55
    Resistance 3 (R3) 0.56 0.54 0.54
    Resistance 2 (R2) 0.54 0.53 0.54 0.54
    Resistance 1 (R1) 0.52 0.52 0.51 0.51 0.53
    Pivot Point 0.50 0.50 0.50 0.50 0.50
    Support 1 (S1) 0.48 0.49 0.47 0.47 0.45
    Support 2 (S2) 0.46 0.48 0.46 0.45
    Support 3 (S3) 0.44 0.46 0.44
    Support 4 (S4) 0.43